The present invention relates to novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers including R and S isomers, polymorphs, prodrugs, metabolites, salts or solvates thereof. The invention also relates to processes for the synthesis of novel compounds of Formula I, their pharmaceutically acceptable derivatives, tautomeric forms, stereoisomers, polymorphs, prodrugs, metabolites, salts or solvates thereof.
本发明涉及公式I的新化合物,其药学上可接受的衍
生物,互变异构体,立体异构体包括R和S异构体,多晶型,前药,代谢物,盐或溶剂的形式。该发明还涉及用于合成公式I的新化合物,其药学上可接受的衍
生物,互变异构体,立体异构体,多晶型,前药,代谢物,盐或溶剂的过程。